Table 2.
Characteristics of patients
| Characteristics at diagnosis | Number of patients (%) |
|---|---|
| Median age, years (range) | 27 (14–76) |
| Sex (male/female) (%) | 50%/50% |
| ECOG PS >2 | 2 (8%) |
| Ann Arbor stage III–IV | 13 (54%) |
| IPS >2 | 11 (49%) |
| B symptoms | 12 (50%) |
| >1 extranodal site | 6 (25%) |
| Bulky disease | 6 (25%) |
| Characteristics pre-GemOx | |
| Median previous lines (range) | 2 (1–6) |
| >1 previous line | 17 (71%) |
| Previous ASCT | 10 (42%) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; PS, performance status; IPS, International Prognostic Score; GemOx, gemcitabine and oxaliplatinum; ASCT, autologous stem cell transplantation.